Hana Kunkel
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
Journal: Human gene therapy. Clinical development
Published: April 18, 2018
Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerization.
Journal: Haematologica
Published: February 04, 2017
Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice.
Journal: Oncotarget
Published: May 12, 2015
A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells.
Journal: Nucleic acids research
Published: January 22, 2015
CD133-targeted gene transfer into long-term repopulating hematopoietic stem cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 05, 2014
PGE2/EP4 signaling in peripheral immune cells promotes development of experimental autoimmune encephalomyelitis.
Journal: Biochemical pharmacology
Published: September 26, 2013
Prostacyclin mediates neuropathic pain through interleukin 1β-expressing resident macrophages.
Journal: Pain
Published: July 25, 2013
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease.
Journal: Human gene therapy. Clinical development
Published: July 13, 2013
Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 05, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026